BusinessStrongbridge Biopharma plc Provides Updates on KEVEYIS® Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 7, 2017, 11:00 AM UTC
BusinessCrinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808By Nasdaq OMXJul 13, 2017, 5:00 PM UTC
BusinessStrongbridge Biopharma plc Provides Corporate and Financial UpdateBy Nasdaq OMXDec 23, 2016, 1:03 PM UTC
BusinessChiasma Joins Patient Organizations Worldwide in Support of Rare Disease DayBy Nasdaq OMXFeb 29, 2016, 1:00 PM UTC
